10-Q Filing

STREAMEX CORP. CIK: 1530766 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001185185-20-000595`
Period End Date	20200331
Filing Date	20200511
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	bsgm-20200331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 32 Cash Flow Statement 52 Stockholders Equity 27

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$12.11M	USD	Point-in-time
Cash	`Cash`	$15.50M	USD	Point-in-time
Inventory	`InventoryNet`	$800.00K	USD	Point-in-time
Inventory	`InventoryNet`	$577.69K	USD	Point-in-time
Vendor deposits	`DepositAssets`	$100.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$160.71K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$141.22K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$16.56M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.83M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$180.37K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$115.12K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$180.37K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$184.58K	USD	Point-in-time
Accounts payable and accrued expenses, related parties (in Dollars)	`AccountsPayableRelatedPartiesCurrent`	$39.67K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$714.34K	USD	Point-in-time
Right-to-use assets, net	`OperatingLeaseRightOfUseAsset`	$614.90K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$359.79K	USD	Point-in-time
Patents, net	`FiniteLivedIntangibleAssetsNet`	$364.54K	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.12K	USD	Point-in-time
Trademarks	`IndefiniteLivedTrademarks`	$1.12K	USD	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$27.41K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Prepaid expenses, long term	`PrepaidExpenseNoncurrent`	$18.22K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$101.84K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$101.84K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total assets	`Assets`	$17.84M	USD	Point-in-time
Total assets	`Assets`	$14.22M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.01M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.32M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.01M	shares	Point-in-time
Accounts payable and accrued expenses, including $115,117 and $39,674 to related parties as of March 31, 2020 and December 31, 2019, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.49M	USD	Point-in-time
Accounts payable and accrued expenses, including $115,117 and $39,674 to related parties as of March 31, 2020 and December 31, 2019, respectively	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.03M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$128.48K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$127.26K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$412.29K	USD	Point-in-time
Lease liability, short term	`OperatingLeaseLiabilityCurrent`	$423.67K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.03M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.58M	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$311.13K	USD	Point-in-time
Lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$201.32K	USD	Point-in-time
Total debt	`LiabilitiesNoncurrent`	$2.34M	USD	Point-in-time
Total debt	`LiabilitiesNoncurrent`	$1.79M	USD	Point-in-time
Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$215.00K	USD	Point-in-time
Preferred Stock	`TemporaryEquityCarryingAmountAttributableToParent`	$205.00K	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 26,010,318 and 23,323,087 issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$23.32K	USD	Point-in-time
Common stock, $0.001 par value, authorized 200,000,000 shares, 26,010,318 and 23,323,087 issued and outstanding as of March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$26.01K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$131.34M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$115.91M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-104.79M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-116.12M	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc	`StockholdersEquity`	$11.15M	USD	Point-in-time
Total stockholders' equity attributable to BioSig Technologies, Inc	`StockholdersEquity`	$15.24M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$514.83K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$607.15K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.19M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$14.22M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$17.84M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$4.93M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.49M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.86M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.38M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$7.93K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$21.02K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.88M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$12.80M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-12.80M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.88M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$6.12K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$39.58K	USD	1 Quarter
Gain on disposal of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Gain on disposal of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-12.76M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-5.87M	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income taxes (benefit)	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.87M	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.76M	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$4.62K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$10.54K	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.88M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.77M	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.43M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO BIOSIG TECHNOLOGIES, INC.	`NetIncomeLoss`	$-5.88M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO BIOSIG TECHNOLOGIES, INC.	`NetIncomeLoss`	$-11.34M	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.46	USD	1 Quarter
Net loss per common share, basic and diluted (in Dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	17.85M	shares	1 Quarter
Weighted average number of common shares outstanding, basic and diluted (in Shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	24.39M	shares	1 Quarter

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-5.87M	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.76M	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$7.93K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$21.02K	USD	1 Quarter
Equity based compensation	`ShareBasedCompensation`	$2.67M	USD	1 Quarter
Equity based compensation	`ShareBasedCompensation`	$4.41M	USD	1 Quarter
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	1 Quarter
Fair value of subsidiary stock issued to acquire research and development from Trek Therapeutics, PBC	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.17M	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$222.31K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	-	USD	1 Quarter
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	$100.00K	USD	1 Quarter
Vendor deposits	`IncreaseDecreaseInDepositsOutstanding`	-	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$10.29K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-21.86K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-455.51K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-354.27K	USD	1 Quarter
Lease liability, net	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.40K	USD	1 Quarter
Lease liability, net	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.02K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.52M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.94M	USD	1 Quarter
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	-	USD	1 Quarter
Payments of patent costs	`PaymentsToAcquireIntangibleAssets`	$58.33K	USD	1 Quarter
Payment of trademark costs	`PaymentsToAcquireOtherProductiveAssets`	$275.00	USD	1 Quarter
Payment of trademark costs	`PaymentsToAcquireOtherProductiveAssets`	-	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.42K	USD	1 Quarter
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.48K	USD	1 Quarter
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-20.48K	USD	1 Quarter
Net cash used in investing activity	`NetCashProvidedByUsedInInvestingActivities`	$-73.02K	USD	1 Quarter
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$8.62M	USD	1 Quarter
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$9.05M	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$301.62K	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.46M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.35M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.08M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$3.39M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$6.48M	USD	1 Quarter
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$10.93M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.50M	USD	Point-in-time
Cash and cash equivalents, beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.45M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$15.50M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$10.93M	USD	Point-in-time
Cash and cash equivalents, end of the period	`CashAndCashEquivalentsAtCarryingValue`	$12.11M	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during the period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$10.54K	USD	1 Quarter
Dividend payable on preferred stock charged to additional paid in capital	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$4.62K	USD	1 Quarter
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	$422.21K	USD	1 Quarter
Right-to-use assets and lease liability recorded upon adoption of ASC 842	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	-	USD	1 Quarter

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.19M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	26.01M	shares	Point-in-time
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$2.33M	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$8.62M	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$9.05M	USD	1 Quarter
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	2.50M	shares	1 Quarter
Warrant subscription exercise received	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$309.00K	USD	1 Quarter
Common stock issued upon exercise of warrants	`ProceedsFromWarrantExercises`	$301.62K	USD	1 Quarter
Common stock issued upon exercise of warrants	`ProceedsFromWarrantExercises`	$1.46M	USD	1 Quarter
Common stock issued upon exercise of warrants (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	309,630.00	shares	1 Quarter
Change in fair value of modified options	`OtherNoncashExpense`	$3.17M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$336.81K	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$4.41M	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$4.62K	USD	1 Quarter
Preferred Stock dividend	`DividendsPreferredStock`	$10.54K	USD	1 Quarter
Net loss	`ProfitLoss`	$-5.87M	USD	1 Quarter
Net loss	`ProfitLoss`	$-12.76M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.85M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.19M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.66M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.32M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	23.32M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	26.01M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.